Fat cells allow melanoma cells to penetrate the dermis, from which they spread, causing fatal metastases in vital organs, TAU researchers say
Researchers at Tel Aviv University, led by Prof. Carmit Levy and Dr. Tamar Golan of the Department of Human Genetics and Biochemistry at TAU’s Sackler School of Medicine, have discovered that fat cells are involved in the transformation that melanoma cells undergo from cancer cells of limited growth in the epidermis to lethal metastatic cells attacking patients’ vital organs.
“We have answered a major question that has preoccupied scientists for years,” explains Prof. Levy. “What makes melanoma change form, turning aggressive and violent? Locked in the skin’s outer layer, the epidermis, melanoma is very treatable; it is still Stage 1, it has not penetrated the dermis to spread through blood vessels to other parts of the body and it can simply be removed without further damage.
“Melanoma turns fatal when it ‘wakes up,’ sending cancer cells to the dermis layer of skin, below the epidermis, and metastasizing in vital organs. Blocking the transformation of melanoma is one of the primary targets of cancer research today, and we now know fat cells are involved in this change.””
The research was conducted in collaboration with several senior pathologists: Dr. Hanan Vaknin of Wolfson Medical Center, and Dr. Dov Hershkowitz and Dr. Valentina Zemer of Tel Aviv Medical Center.
The study was on published July 23 in Science Signaling and is featured on the journal’s cover.
In the study, the researchers examined dozens of biopsy samples taken from melanoma patients at Wolfson Medical Center and Tel Aviv Medical Center, and observed a suspicious phenomenon: fat cells near the tumor sites.
“We asked ourselves what fat cells were doing there and began to investigate,” adds Prof. Levy. “We placed the fat cells on a petri dish near melanoma cells and followed the interactions between them.”
The researchers observed fat cells transferring proteins called cytokines, which affect gene expression, to the melanoma cells.
“Our experiments have shown that the main effect of cytokines is to reduce the expression of a gene called miRNA211, which inhibits the expression of a melanoma receptor of TGF beta, a protein that is always present in the skin,” says Prof. Levy. “The tumor absorbs a high concentration of TGF beta, which stimulates melanoma cells and renders them aggressive.”
Critically, the researchers have also found a way to block this transformation.
“It is important to note that we found the process reversible in the laboratory: When we removed the fat cells from the melanoma, the cancer cells calmed down and stopped migrating,” adds Prof. Levy.
A trial of mouse models of melanoma yielded similar results: When miRNA211 was repressed, metastases were found in other organs, while re-expressing the gene blocked metastases formation.
In the search for a potential drug based on the new discovery, the researchers experimented with therapies that are known to inhibit cytokines and TGF beta, but which have never before been used to treat melanoma.
“We are talking about substances that are currently being studied as possible treatments for pancreatic cancer, and are also in clinical trials for prostate, breast, ovarian and bladder cancers,” Dr. Golan said. “We saw that they restrained the metastatic process, and that the melanoma returned to its relatively ‘calm’ and dormant state.”
“Our findings can serve as a basis for the development of new drugs to halt the spread of melanoma — therapies that already exist, but were never used for this purpose,” concludes Prof. Levy. “In the future, we are seeking to collaborate with drug companies to enhance the development of the metastatic melanoma prevention approach.”
The Latest on: Melanoma
via Google News
The Latest on: Melanoma
- Bend is a ‘perfect storm’ for melanomaon August 16, 2019 at 12:01 am
For more details on how to check your skin or how to get involved in the War on Melanoma campaign, visit startseeingmelanoma.com Wearing sunscreen today? If the answer is no, maybe you should be.
- MDM2 counteracts resistance to CDK4/6 inhibitors for melanoma therapyon August 15, 2019 at 1:38 pm
A study from Vanderbilt-Ingram Cancer Center and the Department of Veterans Affairs led by Anna Vilgelm, MD, Ph.D., and Ann Richmond, Ph.D., has identified a possible second-line treatment for ...
- A new treatment for advanced melanoma patients on Coast Liveon August 14, 2019 at 12:01 pm
HAMPTON ROADS, Va. - Melanoma is the most serious and life-threatening type of skin cancer. It is almost always treatable when caught early, but if it metastasizes, or spreads to other parts of ...
- Genetic test helped Utahns at risk for melanoma change behavior, study findson August 9, 2019 at 5:27 pm
SALT LAKE CITY — When people know they have a high genetic risk of melanoma, they are more likely to protect themselves from the sun, according to a new study. "For most genes that have been found for ...
- Combo Tx for Melanoma Ups CV Riskon August 9, 2019 at 11:11 am
Dual BRAF and MEK inhibition therapy for melanoma may carry certain cardiovascular harms, according to a meta-analysis. Across five randomized trials with a total of 2,317 patients, the addition of ...
- Melanoma Checkpoint Therapy More Potent in Combination with Nanovaccineon August 6, 2019 at 3:29 am
Dissonant signaling, which can deafen the immune system to cancer, can be replaced by something more harmonious—and therapeutic—if immunotherapies silence a note, sound another, or play an especially ...
- Scientists demonstrate a new nano-vaccine preventing the spread of melanomaon August 5, 2019 at 9:41 pm
A new nano-vaccine both slowed the progression of skin cancer in mice with a primary melanoma, and prevented its initial onset in healthy mice(Credit: vitanovski/Depositphotos) A new nano-vaccine ...
- Man bikes across America to raise awareness for melanomaon August 5, 2019 at 4:23 pm
A Waukesha County man is biking across America to raise money and awareness about melanoma. He's riding for his sister Barbie. She lost her battle with melanoma last year at the age of 58.
- Skin cancer nano-vaccine protects mice from deadly melanoma cellson August 5, 2019 at 2:12 pm
Melanoma, the most deadly skin cancer, may one day be prevented and treated using a simple vaccine. Researchers with Tel Aviv University have published the results of their work with nanoparticles and ...
- Novel nano-vaccine for melanomaon August 5, 2019 at 11:53 am
Researchers have developed a novel nano-vaccine for melanoma, the most aggressive type of skin cancer. Their approach has so far proven effective in preventing the development of melanoma in mouse ...
via Bing News